[1. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res. 2009; 39: 107-16.10.1111/j.1872-034X.2008.00441.x19208031]Open DOISearch in Google Scholar
[2. Manizate F, Hiotis SP, Labow D, Roayaie S, Schwartz M. Liver functional reserve estimation: state of the art and relevance to local treatments. Oncology. 2010; 78: 131-4.10.1159/00031524120616595]Open DOISearch in Google Scholar
[3. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31:864-71.10.1053/he.2000.585210733541]Open DOISearch in Google Scholar
[4. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003; 52:134-9.10.1136/gut.52.1.134177350912477775]Open DOISearch in Google Scholar
[5. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33:464-70.10.1053/jhep.2001.2217211172350]Open DOISearch in Google Scholar
[6. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd- EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology. 1995; 195:785-92.10.1148/radiology.195.3.77540117754011]Search in Google Scholar
[7. Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology. 1996; 199:177-83.10.1148/radiology.199.1.86331438633143]Search in Google Scholar
[8. Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology. 2005; 237: 89-98.10.1148/radiol.237103184216126918]Search in Google Scholar
[9. Ryeom HK, Kim SH, Kim JY, Kim HJ, Lee JM, Chang YM, et al. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol. 2004; 5:231-9.10.3348/kjr.2004.5.4.231269816715637473]Open DOISearch in Google Scholar
[10. Tajima T, Takao H, Akai H, Kiryu S, Imamura H, Watanabe Y, et al. Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr. 2010; 34:362-6.10.1097/RCT.0b013e3181cd330420498536]Search in Google Scholar
[11. Katsube T, Okada M, Kumano S, Hori M, Imaoka I, Ishii K, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011; 46:277-83.10.1097/RLI.0b013e318200f67d21343827]Open DOISearch in Google Scholar
[12. Katsube T, Okada M, Kumano S, Imaoka I, Kagawa Y, Hori M, et al. Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging. Eur J Radiol. 2012; 81:1460-4.10.1016/j.ejrad.2011.03.07321514080]Open DOISearch in Google Scholar
[13. Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, Sato T, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol. 2011; 80:e311-6.10.1016/j.ejrad.2011.01.02021315529]Open DOISearch in Google Scholar
[14. Nakamura S, Awai K, Utsunomiya D, Namimoto T, Nakaura T, Morita K, et al. Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement? Jpn J Radiol. 2012; 30:25-33.]Search in Google Scholar
[15. Verloh N, Haimerl M, Zeman F, Schlabeck M, Wiggermann P, et al. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol. 2014; 24:1013-9.10.1007/s00330-014-3108-y24531844]Open DOISearch in Google Scholar